News

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...
Pulmonary Hypertension News5h
Ultrasound device for PH nets FDA breakthrough device designation
The ultrasound catheter is being tested in the PreVail-PH2 study, an early feasibility trial enrolling PH patients with left ...
What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
COPD News Today9h
FDA approves Nucala as add-on therapy for certain COPD patients
The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...
Medical Device Network on MSN13h
Qiagen and ID Solutions collaborate on dPCR assays for oncology research
ID Solutions will produce and supply dPCR assays for use in non-clinical research on Qiagen's QIAcuity platforms.
KIVI-TV23h
FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals
The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.